tirzepatide itching Tirzepatide-Induced Injection Site Reaction tirzepatide and itchy skin Joints,
Description
This trial enrolled adults with obesity, both with and without type 2 diabetes, and evaluated multiple doses of retatrutide administered once weekly over 24 and 48 weeks

doi: 10.1186/s13195-022-00996-8
B., Volkow, N

March 19, 2025 for 503B) Published Clinical Data: SURMOUNT-1 trial published in New England Journal of Medicine (Jastreboff et al., 2022) Independent Surveys: Gallup Health and Well-Being Index (October 2025)
This table separates starter price from realistic ongoing cost

Graphs are digestible, language is jargon-free, and navigation is intuitive
